- 21 September
-
On September 11–17, 2026, Ekaterinburg hosted the International Youth Festival, a large-scale event that brought together 10,000 young leaders from 191 countries. At the festival running under the motto «Follow Your Dream,» the Medsintez Plant presented its exhibition, showcasing the achievements of the Ural pharmaceutical industry in the field of import substitution.
- 18 September
-
The updated clinical guidelines for treatment of ARVI in children took effect on September 2, 2026. The document was developed by leading experts from the Union of Pediatricians of Russia, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and the Russian Society of Emergency Medical Care and approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. It fundamentally shifts therapeutic approaches toward enhanced safety and minimal drug burden.
- 14 September
-
On September 3–4, 2026, Nizhny Novgorod hosted the 2nd Regional Endocrinological Congress: Challenges and Prospects of the Volga Region, with the active participation of the Medsintez Plant. As a strategic company, Medsintez Plant has been ensuring Russia's pharmaceutical security for 25 years. Company's exhibition booth showcased a range of hormonal medications for treatment of type 1 and type 2 diabetes, as well as drugs for infertility treatment through the IVF method.
- 04 September
-
More than twenty years ago, the Regiony Rossii (Regions of Russia, RR) magazine witnessed the birth of an innovative pharmaceutical production facility in Novouralsk, which had no analogues in the country. Today, the Medsintez Plant is a strategic asset in terms of national pharmaceutical security, a recognized industry leader, a National Champion, and a winner of prestigious awards. The secret behind the success of the Ural school of pharmaceuticals and biotechnology is explored in this article by RR.
- Home
- Cluster members
- Vector-Medical Systems LLC
Vector-Medical Systems LLC
Since 1993, the medical and technical enterprise Vector-MS LLC has been specializing in the development and production of equipment for cardiology, cardiac surgery, functional diagnostics, physiotherapy, traumatology and rehabilitation.
Since 1993, the company has developed and put into mass production more than 10 medical devices.
The company includes a design office, pilot production, medical and technical department, marketing and sales department, as well as supporting services.
The company operates in five areas:
The first area is scientific research (R&D).
Based on the results of R&D, the company has obtained five patents.
The second area is the production of medical devices.
We produce:
1) External pacemakers:
- Transesophageal endocardial pacemaker CHEECS-3 «Vector-MS»
- For temporary external cardiac pacing in transesophageal, endocardial and transcutaneous modes.
- For the diagnostics and treatment of rhythm and conduction disorders of the heart.
- Programmable transesophageal and endocardial pacemaker CHEECSp-3 “Vector-MS”
Designed for electrophysiological studies of human cardiac activity, diagnostics and treatment of cardiac arrhythmias and conduction disorders in transesophageal and endocardial modes.
- Transesophageal endocardial and transcutaneous pacemaker CHEECS-5 “Vector-MS”
- diagnostics and treatment cardiac arrhythmias;
- conducting temporary pacemaking in order to stop arrhythmias in any conditions (including field ones) and maintain cardiac function in critical situations (ambulance) with simultaneous ECG monitoring in two leads;
- electrophysiological studies of the heart;
- intraoperative determination of the stimulation threshold and load impedance of the pacemaker of LLC «Vector-Medical Systems».
- Temporary wearable single-dual-chamber pacemaker ECS-VN-12 “Vector-MS”
For temporary endocardial stimulation of one or two cardiac chambers in patients with rhythm disturbances.
- Temporary portable transcutaneous transesophageal endocardial pacemaker ECS-VP-3 “Vector-MS”
For temporary transcutaneous, transesophageal and endocardial electrical stimulation of the heart when providing emergency care to patients with severe bradycardia, who are in serious condition due to extensive myocardial damage with severe disorders of central hemodynamics.
2) ELECTROSTIMULATOR ANALGETIC ESP-01- (according to A.A. Gerasimov) “Vector-MS”
Intratissual and transcutaneous electrical stimulation (ITES) according to the method of Doctor of Medical Sciences, Professor A.A. Gerasimov is a modern drug- free method for the treatment of diseases of the spine, joints, headaches and other pain syndromes.
3) Programmable transesophageal and endocardial pacemaker CHEECSp-3 “Vector-MS”
The production and maintenance of medical equipment is licensed (license of the Federal Service for Supervision in the Sphere of Health Care No. ФС-99-03-003878 dated 20/5/2013). All manufactured medical equipment has registration certificates of the Russian Federation.
The company sells its products both on the territory of the Russian Federation and in the CIS countries
The third area is maintenance of medical equipment.
In the scope of a maintenance license.
The fourth area is the supply of medical devices and consumables to healthcare institutions in Ekaterinburg and the Urals Federal District.
We are representatives of Inkart CJSC (St. Petersburg), Vilord LLC (Moscow), Neurosoft LLC (Ivanovo), Medicraft LLC and others.
The fifth area is the development of a home rehabilitation program.
Lease of medical equipment for rehabilitation.
Contacts:
50A, Bibliotechnaya St., Ekaterunburg, 620078
Tel.: +7 (343) 374-43-08
e-mail: market@vectorms.ru
www.vectorms.ru
